Table 5.
Vaccines approved after phase 3 trials. The details on name of the vaccine, vaccine type, vaccine developers, vaccine effectiveness, dose, storing temperature with their origin country are listed.
| S. No. | Name | Vaccine type | Vaccine developers | Efficacy | Dose | Storage | Origin (Country) |
|---|---|---|---|---|---|---|---|
| 1. | Comirnaty (BNT162b2) | mRNA-based vaccine | Pfizer, BioNTech, and Fosun Pharma | 95% | 2 doses (Muscle injection) | −94 °F (−70 °C) | Multinational |
| 2. | Moderna | COVID-19 mRNA-based Vaccine (mRNA-1273) | Moderna, BARDA, NIAID | 94.5% | 2 doses (Muscle injection) | 6 months at −4 °F | US |
| 3. | AstraZeneca (AZD1222) | Adenovirus vaccine | BARDA | 62% to 90% | 2 doses (Muscle injection) | 6 months at −4 °F | UK |
| 4. | Convidecia (Ad5-nCoV) | Recombinant vaccine | CanSino Biologics | – | 1 dose (Muscle injection) | Refrigerator | China |
| 5. | Covaxin (BBV152 A, B, C) | Inactivated vaccine | Bharat Biotech, ICMR | – | 2 doses (Muscle injection) | Room temperature | India |
| 6. | Sputnik V | Non-replicating viral vector | Acellena Contract Drug Research and Development | 91.4% | 2 doses (Muscle injection) | Freezer storage | Russia |
| 7. | CoronaVac (PiCoVacc) | Inactivated vaccine | National Pharmaceutical Group | 50.38% | 2 doses (Muscle injection) | Refrigerator | China |
| 8. | BBIBP | Inactivated vaccine | Beijing Institute of Biological Products | 79.34% | 2 doses (Muscle injection) | – | China |
| 9. | EpiVac Corona | Peptide vaccine | Federal Budgetary Research Institution State Research Center of Virology and Biotechnology | – | 2 doses (Muscle injection) | Refrigerator | Russia |
| 10. | Comirnaty (BNT162b2) | mRNA-based vaccine | Pfizer, BioNTech; F osun Pharma | 95% | 2 doses (Muscle injection) | −94 °F (−70 °C) | Multinational |